-+ 0.00%
-+ 0.00%
-+ 0.00%

Xenon Pharmaceuticals shares fell 27.5% in the premarket after the company suspended new patient recruitment for depression drug trials.

智通财经·09/18/2026 08:09:03
语音播报
Xenon Pharmaceuticals shares fell 27.5% in the premarket after the company suspended new patient recruitment for depression drug trials.